N/A N=10 Transcranial Near-Infrared Light in Healthy Subjects: a Cerebral Blood Flow Study With Diffuse Correlation Spectroscopy
Cognitive Change
Primary: Change in Cerebral Blood Flow (Baseline to Week 5) — 2.15 mm2/s
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=86 Arrhythmia Detection In Obstructive Sleep Apnea (ADIOS)
Atrial Fibrillation · Arrhythmia · Stroke, Cardiovascular
Primary: Number of Participants With Definite Atrial Fibrillation (Defined as an Irregularly Irregular Rhythm With Absence of p Waves) — 2 Participants
Phase 2 N=96 Mirvetuximab Soravtansine as First Line in Treating Patients With Triple Negative Breast Cancer
Anatomic Stage II Breast Cancer AJCC v8 · Anatomic Stage IIA Breast Cancer AJCC v8 · Anatomic Stage IIB Breast Cancer AJCC v8
Primary: Number of Metastatic Participants With Radiographic Response — 0 Participants
Phase 2 N=20 Allogenic Cord Blood Transfusion in Patients With Autism
Autism Spectrum Disorder · Autism
Primary: A Number of Participants With Non-serious and Serious Adverse Events 24 Hrs Post-transfusion — 0; 0; 0; 0 participants
Phase 2 N=18 11C- and 18F-Choline PET/MR Imaging for Prostate Cancer
Prostate Cancer
Primary: Mean Kinetic Parameters Reflecting Fluorocholine (FCH) Fluorine 18 FCH (F-18) Influx (K1) — 0.562 K1 (min-1)
Phase 1 N=15 Phase I/Ib Study of Nivolumab & Veliparib in Patients With Advanced Solid Tumors & Lymphoma
Advanced Solid Neoplasm · Aggressive Non-Hodgkin Lymphoma · Recurrent Solid Neoplasm
Primary: Maximum Tolerated Dose (MTD) — 400 mg
N/A N=63 A Randomized Study of Sulindac in Oral Premalignant Lesions
Leukoplakia, Oral · Benign Neoplasms
Primary: - To Evaluate the Efficacy of Sulindac in Subjects With Early or Advanced Oral Premalignant Lesion (OPL) by Both Clinical Response (Reduction in Size of All Lesions) and…
N/A N=251 A Study to Evaluate the Safety and Efficacy of Kalifilcon A Daily Disposable Contact Lens
Contact Lens Wear
Primary: Mean logMAR Contact Lens Visual Acuity — -0.066; -0.060 units on a scale
Phase 2 N=7 Clinical Trial of the Safety and Efficacy of the Addition of Ramucirumab to Nab-paclitaxel in Previously Treated Patients With Advanced Non-small Cell Lung Cancer (NSCLC)
Non-small Cell Lung Cancer
Primary: Progression-free Survival (PFS) — 8.16 months
Phase 3 N=139 Long-term Safety Study of Sublingual Fentanyl Tablets in Cancer Patients
Pain · Cancer
Primary: Evaluate the Long-term Safety and Effectiveness of EN3267 — 64; 87; 116; 14 participants
Phase 2 N=24 A Study to Determine the Safety and Effectiveness of RAD001 (Everolimus) in Patients With Lymphangioleiomyomatosis
Lymphangioleiomyomatosis
Primary: Change From Baseline in Vascular Endothelial Growth Factor-D (VEGF-D) Concentrations — -464.3; -1113.2; -1771.7 pg/mL
Phase 2 N=191 A Study Of PF-04447943 Compared To Placebo In Subjects With Mild To Moderate Alzheimer's Disease
Alzheimer's Disease
Primary: Alzheimer's Disease Assessment Scale-Cognitive Subscale 70 (ADAS-Cog 70) Score at Baseline — 21.87; 22.66 units on a scale
N/A N=712 Evaluation of an Interactive Opioid Risk Education Program (STOMP) for Parents
Pain, Postoperative · Medication Adherence · Opioid Use
Primary: Opioid-related Risk Knowledge — 287; 289 Participants
N/A N=60 The Use of STRATAFIX Suture Device Compared to Standard-of-care for Deep Tissue Closure in Total Knee Arthroplasty
Wound; Knee
Primary: Time to Close, Minutes — 19; 28 minutes
N/A N=2,370 Folic Acid and Zinc Supplementation Trial (FAZST)
Pregnancy · Live Birth · Spontaneous Abortion
Primary: Live Birth — 404; 416; 97; 91 Participants